Related references
Note: Only part of the references are listed.MicroRNA-223 Regulates Cyclin E Activity by Modulating Expression of F-box and WD-40 Domain Protein 7
Yanfei Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
Takehiko Yokobori et al.
CANCER RESEARCH (2009)
Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes
Jyh-Cherng Yu et al.
CARCINOGENESIS (2009)
The methylation status of FBXW7 β-form correlates with histological subtype in human thymoma
Zhaodi Gu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Fbxw7 in cell cycle exit and stem cell maintenance Insight from gene-targeted mice
Ichiro Onoyama et al.
CELL CYCLE (2008)
FBXW7 and DNA copy number instability
Kristin N. Byrd et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yutaka Yamamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis
Ichiro Onoyama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
FBXW7/hCDC4 is a general tumor suppressor in human cancer
Shahab Akhoondi et al.
CANCER RESEARCH (2007)
Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2007)
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients
Martin Hagedorn et al.
CELL DIVISION (2007)
Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer
Ceshi Chen et al.
MOLECULAR CANCER RESEARCH (2006)
Cyclin E expression and prognosis in breast cancer patients: A meta-analysis of published studies
Lei Wang et al.
CANCER INVESTIGATION (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
GM Callagy et al.
CLINICAL CANCER RESEARCH (2006)
Meeting highlights:: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
A Goldhirsch et al.
ANNALS OF ONCOLOGY (2005)
c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells
S Mukherjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mouse Fbw7/Sel-10/Cdc4 is required for Notch degradation during vascular development
R Tsunematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer
SE Reed et al.
CANCER RESEARCH (2004)
Prognostic relevance of gene amplifications and coamplifications in breast cancer
K Al-Kuraya et al.
CANCER RESEARCH (2004)
Meeting highlights:: Updated international expert consensus on the primary therapy of early breast cancer
A Goldhirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
CM Schlotter et al.
BREAST CANCER RESEARCH (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line
H Strohmaier et al.
NATURE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Insulin/Insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21WAF1/Cip1
A Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
SL Deming et al.
BRITISH JOURNAL OF CANCER (2000)